Newswire (Published: Tuesday, April 4, 2017, Received: Thursday, March 30, 2017, 8:11:44 PM CDT)
Word Count: 472
By a News Reporter-Staff News Editor at Cancer Weekly -- Investigators publish new report on Brachytherapy. According to news reporting out of Edmonton, Canada, by NewsRx editors, research stated, "Permanent prostate brachytherapy is an effective and popular treatment modality for prostate cancer in which long needles are inserted into the prostate. Challenges associated with manual needle insertion such as needle deflection limit this procedure to primarily treat the entire prostate gland even for patients with localized cancer."
Financial supporters for this research include Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research, Alberta Innovates-Health Solutions (see also Brachytherapy).
Our news journalists obtained a quote from the research from the University of Alberta, "In this paper, we present a new semiautomated hand-held needle steering assistant designed to help surgeons improve needle placement accuracy. Regular clinical brachytherapy needles are connected to a compact device that the surgeon holds. As the surgeon inserts the needle, the device rotates the needle base on a measured and calculated basis in order to produce a desired trajectory of the needle tip. A novel needle-tissue interaction model and a steering algorithm calculate such control actions based on ultrasound images of the needle in tissue. The assistant can also apply controlled longitudinal microvibrations to the needle that reduce needle-tissue friction. Experimental validation of the proposed system in phantom and ex-vivo biological tissue report an average needle targeting accuracy of 0.33 mm over 72 needle insertions in 12 different experimental scenarios. We introduce a new framework for needle steering in prostate brachytherapy in which the surgeon remains in charge of the needle insertion. The device weighs 160 g, making it easy to incorporate with current insertion techniques."
According to the news editors, the research concluded: "Expected benefits of the proposed system include more precise needle targeting accuracy, which can result in improved focal treatment of prostate cancer."
For more information on this research see: A Hand-Held Assistant for Semiautomated Percutaneous Needle Steering. IEEE Transactions on Biomedical Engineering, 2017;64(3):637-648. IEEE Transactions on Biomedical Engineering can be contacted at: Ieee-Inst Electrical Electronics Engineers Inc, 445 Hoes Lane, Piscataway, NJ 08855-4141, USA. (Institute of Electrical and Electronics Engineers - www.ieee.org/; IEEE Transactions on Biomedical Engineering - ieeexplore.ieee.org/xpl/RecentIssue.jsp?punumber=10)
Our news journalists report that additional information may be obtained by contacting C. Rossa, University of Alberta, Dept. of Elect & Comp Engn, Edmonton, AB T6G 2V4, Canada. Additional authors for this research include N. Usmani, R. Sloboda and M. Tavakoli.
Keywords for this news article include: Edmonton, Alberta, Canada, North and Central America, Drugs and Therapies, Brachytherapy, Radiotherapy, Oncology, Therapy, Cancer, University of Alberta.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC
Alberta Innovates Health Solutions
University of Alberta
The Institute of Electrical and Electronics Engineers Incorporated
Science and Technology
Health and Wellness
Medical Conditions and Diseases
Men's Health Issues